Ostre niewydolność wątroby
Rokowania, prognozy i postęp choroby
Ostra niewydolność wątroby (ALF) to zespół kliniczny o wysokim ryzyku śmiertelności bez przeszczepienia. Kluczowa jest dokładna ocena prognostyczna, wykorzystująca m.in. kryteria Clichy i King’s College Hospital (KCH), choć ich zastosowanie jest ograniczone przez dostępność i czułość. W ALF wywołanej paracetamolem, złe rokowanie wiąże się z pH tętniczym <7,3, PT >100 s lub kreatyniną >300 μg/ml (3,4 mg/dl). W ALF niezwiązanej z paracetamolem, PT >100 s oraz co najmniej trzy z pięciu kryteriów (wiek <10 lub >40 lat, etiologia non-A/non-B, czas żółtaczki >7 dni, PT >50 s, bilirubina >300 μmol/L) wskazują na zły prognostyk. Modele MELD (>23,5) i jego modyfikacje (CATCH-LIFE-MELD, MELD-complication) poprawiają ocenę ryzyka, zwłaszcza w ACLF. Skala CLIF-SOFA przewyższa MELD pod względem czułości, swoistości i AUROC, a jej wersja pediatryczna (pCLIF-SOFA) jest lepsza niż PELD/MELD u dzieci z ALF. Dynamiczna ocena zmian parametrów prognostycznych w ciągu pierwszych dni hospitalizacji dostarcza dokładniejszych informacji o rokowaniu niż pojedyncze pomiary wyjściowe.
Prognostyczne wskaźniki w ostrej niewydolności wątroby
Ostra niewydolność wątroby (ang. acute liver failure, ALF) to ciężki zespół kliniczny charakteryzujący się gwałtownym pogorszeniem funkcji wątroby, który wiąże się z wysokim ryzykiem zgonu bez przeszczepienia wątroby. Dokładna ocena prognostyczna jest kluczowa dla określenia dalszego postępowania z pacjentem, w tym kwalifikacji do przeszczepienia wątroby.12
Tradycyjne skale prognostyczne
Kryteria Clichy i King’s College Hospital (KCH) są najczęściej stosowanymi wskaźnikami prognostycznymi w ALF. Jednak zastosowanie kryteriów Clichy jest ograniczone ze względu na brak powszechnej dostępności pomiaru poziomu czynnika V. Z kolei kryteria KCH charakteryzują się dobrą swoistością, ale niską czułością w przewidywaniu wyników.13
Dla ALF wywołanej zatruciem paracetamolem, kryteria KCH obejmują pH tętnicze poniżej 7,3 oraz czas protrombinowy (PT) większy niż 100 sekund lub poziom kreatyniny większy niż 300 μg/ml (3,4 mg/dl) jako niezależne czynniki predykcyjne złego rokowania.4
W przypadku ALF niezwiązanej z paracetamolem, PT powyżej 100 sekund oraz trzy z pięciu następujących kryteriów wskazują na złe rokowanie:5
- Wiek <10 lub >40 lat
- Etiologia (non-A, non-B hepatitis, idiopatyczna ALF, reakcja na leki)
- Czas trwania żółtaczki przed wystąpieniem encefalopatii >7 dni
- PT >50 sekund
- Poziom bilirubiny w surowicy >300 μmol/L (>17,5 mg/dL)
Model MELD i jego modyfikacje
Model for End-Stage Liver Disease (MELD) jest powszechnie stosowanym wskaźnikiem prognostycznym w przewlekłych chorobach wątroby, a coraz częściej jest wykorzystywany również w ALF. Badania wykazują, że MELD powyżej 23,5 wiąże się z wyższym ryzykiem rozwoju ALF u pacjentów z zapaleniem wątroby typu A.67
Nowsze modyfikacje MELD, takie jak CATCH-LIFE-MELD, wykazują lepszą dokładność w przewidywaniu krótkoterminowego rokowania w ostrej niewydolności wątroby nałożonej na przewlekłą (ACLF) w porównaniu do tradycyjnych skal.8 Model MELD-complication, integrujący wartości laboratoryjne i istotne powikłania kliniczne, poprawia przewidywanie krótkoterminowych wyników u pacjentów z ACLF.9
Skala CLIF-SOFA
Chronic Liver Failure-Sequential Organ Failure Assessment (CLIF-SOFA) jest skalą oceny niewydolności narządów dostosowaną do chorób wątroby. Badania wykazują, że CLIF-SOFA jest lepszym predyktorem śmiertelności niż skala MELD pod względem czułości, swoistości, wartości predykcyjnej ujemnej (NPV), wartości predykcyjnej dodatniej (PPV) i dokładności diagnostycznej.110
Pole pod krzywą charakterystyki operacyjnej odbiornika (AUROC) dla skali CLIF-SOFA jest wyższe w porównaniu do skali MELD.1 Pacjenci, którzy nie przeżyli, mieli wyższe wartości INR, wyższe stopnie encefalopatii wątrobowej (HE), wyższe wyniki MELD i CLIF-SOFA.10
W populacji pediatrycznej, pediatryczna wersja CLIF-SOFA (pCLIF-SOFA) okazała się lepszym predyktorem zgonu niż skala PELD/MELD u dzieci z ALF. Przy wartościach odcięcia 8 dla pCLIF-SOFA i 30 dla PELD/MELD, pCLIF-SOFA wykazała wyższe AUROC (0,88 vs 0,76).11
Dynamiczna ocena prognostyczna
ALF jest procesem dynamicznym, a wartości zmiennych prognostycznych zmieniają się w czasie podczas przebiegu klinicznego pacjenta. Dlatego dynamiczna ocena prognostyczna może dostarczać dokładniejszych informacji o rokowaniu.1213
Znaczenie oceny sekwencyjnej
Badania wykazują, że wczesne zmiany markerów prognostycznych lepiej przewidują wynik niż statyczne poziomy wyjściowe.13 W ACLF większość pacjentów osiąga ostateczny stopień ACLF w ciągu pierwszego tygodnia; dlatego ocena stopnia ACLF w dniach 3-7 po rozpoznaniu przewiduje śmiertelność 28-dniową i 90-dniową dokładniej niż stopień ACLF przy rozpoznaniu.14
Dane z badania CANONIC pokazały ogólną 28-dniową śmiertelność na poziomie 33% wszystkich przypadków ACLF, a specyficzne wskaźniki śmiertelności 28-dniowej u pacjentów z ACLF stopnia 1, 2 i 3 wynosiły odpowiednio 22%, 32% i 73%.15
Modele dynamiczne
Opracowano kilka dynamicznych modeli prognostycznych dla ALF i ACLF. Na przykład, model dynamiczny przewidywania dla pacjentów z ACLF związanym z HBV leczonych analogami nukleozydów (NA) wykazał wyższą wartość AUROC (0,86) w przewidywaniu śmiertelności 90-dniowej w porównaniu do MELD, MELD-Na i CLIF-SOFA.16
Innym przykładem jest model ALFED (ALF Early Dynamic), który uwzględnia dynamikę wczesnych zmian markerów prognostycznych. Porównanie tego modelu z ustalonymi modelami prognostycznymi KCC i MELD wykazało, że skuteczność MELD i kryteriów KCC była gorsza niż model ALFED.13
Zastosowanie elastografii wątroby
Obiecującym narzędziem prognostycznym w ALF jest pomiar sztywności wątroby (LSM) za pomocą elastografii. Badania pilotażowe pokazują, że LSM może być wykorzystany w ostrej niewydolności wątroby i prognozować wynik w 7. dniu przyjęcia.17
Przy przyjęciu LSM prawego płata był statystycznie różny między zdrowymi osobami (5,62 kPa), pacjentami z ALF (31,717 kPa) i pacjentami z ACLF (76,371 kPa).18
Chociaż przy przyjęciu LSM nie różnił się między pacjentami z ALF, którzy przeżyli spontanicznie, a pacjentami, którzy zmarli lub zostali przeszczepieni w ciągu następnych 90 dni, trend w ciągu pierwszych 10 dni przyjęcia był różny. U pacjentów, którzy przeżyli spontanicznie, LSM osiągnął szczyt w 5. dniu, a następnie zmniejszył się podczas fazy zdrowienia. Pacjenci z złym rokowaniem wykazywali stale podwyższony LSM.18
Nowoczesne podejścia do prognozowania ALF
Modele CART
Classification and Regression Tree (CART) to modele, które oferują proste modele prognostyczne dla pacjentów z ALF wywołaną paracetamolem (APAP-ALF), które mają wyższe AUROC i czułość niż KCC, przy podobnej dokładności i nieznacznie gorszej swoistości.19
Opracowano modele prognozowania przy przyjęciu i po przyjęciu. Modele KCC-CART poprawiły znacznie czułość i AUROC oraz zapewniły podobną dokładność predykcyjną w porównaniu do tradycyjnego KCC, podczas gdy modele NEW-CART zapewniały dalszą, ale marginalną poprawę w stosunku do modeli KCC-CART przy przyjęciu.20
Test LiMAx
Test LiMAx (maximal liver function capacity) to obiecujące narzędzie do prognozowania wyników w ALF. Badania pilotażowe sugerują, że maksymalna wydolność czynnościowa wątroby określona przez test LiMAx jest znacznie upośledzona u pacjentów z ALF. Stopień upośledzenia czynnościowego może być cennym parametrem do prognozowania indywidualnego rokowania i potrzeby przeszczepienia wątroby.21
Definicyjną zaletą testu LiMAx jest jego czułość na krótkoterminowe zmiany, której nie może zapewnić żaden test biochemiczny.21
Sarkopenia jako wskaźnik prognostyczny
Sarkopenia okazała się niezależnym czynnikiem ryzyka progresji w populacji ACLF (HR 3,771 95% CI 2,114-6,727, p<0,001).22 Badania sugerują, że sarkopenia jest prostym i obiektywnym wskaźnikiem, który może przewidywać 90-dniowe rokowanie u pacjentów z ACLF.23
Opracowano nowy model AMPAS1, który był dobrym predyktorem niekorzystnych wyników, z obszarem pod krzywą ROC wynoszącym 0,865, a wartością odcięcia dla przewidywania złego wyniku wynoszącą 0,31 (czułość 79,4%, swoistość 76,4%).22
Czynniki wpływające na rokowanie
Czynniki kliniczne i laboratoryjne
Śmiertelność w ALF wiąże się z różnymi czynnikami klinicznymi i laboratoryjnymi. W badaniu obejmującym 154 dzieci z ALF czynnikami prognostycznymi związanymi ze śmiertelnością były podwyższone wartości międzynarodowego współczynnika znormalizowanego (INR), bilirubiny całkowitej (TB), kreatyniny i amoniaku przy prezentacji, z wartościami odcięcia odpowiednio 2,97, 21,15, 0,385 i 212.24
Encefalopatia wątrobowa (HE) okazała się predyktorem śmiertelności w różnych badaniach.10 W badaniu dotyczącym pacjentów z ACLF wyniki wieloczynnikowej analizy ujawniły, że encefalopatia wątrobowa, zakażenie płuc i samoistne bakteryjne zapalenie otrzewnej (SBP) były niezależnymi czynnikami ryzyka śmiertelności krótkoterminowej i były rzeczywiście najważniejszymi powikłaniami dla śmiertelności krótkoterminowej.25
Wpływ etiologii
Etiologia ALF ma znaczący wpływ na rokowanie. Pacjenci z ALF spowodowaną paracetamolem mają lepsze rokowanie niż pacjenci z nieokreśloną formą tego zaburzenia.26 Paradoksalnie, szybka progresja od wystąpienia żółtaczki do encefalopatii jest związana z poprawą przeżycia. Gdy ten odstęp jest krótszy niż 2 tygodnie, pacjenci mają piorunującą niewydolność wątroby (hyperacute liver failure).5
Dynamika powikłań
Ryzyko śmiertelności wzrasta wraz z rozwojem powikłań, takich jak obrzęk mózgu, niewydolność nerek, zespół ostrej niewydolności oddechowej dorosłych (ARDS), koagulopatia i zakażenie.26 Krzywa przeżycia pokazała, że wraz ze wzrostem liczby powikłań, wskaźnik przeżycia pacjentów znacznie się zmniejszał.25
Śmiertelność jest wysoka w ACLF i wzrasta wraz z liczbą niewydolności narządów (40% w ACLF1 do 100% w ACLF3).2728
Praktyczne zastosowania modeli prognostycznych
Podejmowanie decyzji klinicznych
Modele prognostyczne są kluczowe dla podejmowania decyzji klinicznych w ALF, w tym decyzji o przeszczepieniu wątroby. Badania sugerują, że większość pacjentów będzie miała jasne rokowanie między 3 a 7 dniem hospitalizacji, a decyzje kliniczne, takie jak ocena do przeszczepienia wątroby lub dyskusja nad celami opieki, mogą być dostosowane przy użyciu skal klinicznych.15
Wczesna ocena prawdopodobieństwa zgonu jest ważna dla decyzji o pilnym przeszczepieniu wątroby, podczas gdy terminowe przewidywanie spontanicznego wyzdrowienia pomaga zapobiec przeszczepieniu i potrzebie dożywotniej terapii immunosupresyjnej.3
Ograniczenia i wyzwania
Pomimo dostępności różnych modeli prognostycznych, wykazują one niespójną odtwarzalność i dokładność prognostyczną, dlatego nie można ich traktować jako wiarygodnych w przewidywaniu śmiertelności w ALF. Istnieje potrzeba lepszego modelu prognostycznego.313
Przegląd systematyczny zidentyfikował liczne ograniczenia metodologiczne i raportowe w badaniach nad modelami prognostycznymi dla ALF. Przyszłe badania mogłyby zostać ulepszone przez lepsze raportowanie i obchodzenie się z brakującymi danymi, uwzględnienie aspektów kalibracji modelu, wykorzystanie bezwzględnych miar ryzyka, jawne rozważania dotyczące selekcji zmiennych oraz bardziej dokładną walidację.29
Perspektywy na przyszłość
Obecnie trwają badania nad nowymi markerami prognostycznymi i modelami dla ALF. Potrzebne są dalsze badania w większej kohorcie, aby lepiej zrozumieć rolę diagnostyczną sztywności wątroby w ostrej niewydolności wątroby i czy dodanie tych wartości do istniejących kryteriów prognostycznych mogłoby poprawić ich czułość i swoistość.17
Idealny model prognostyczny pozostaje nieuchwytny, ponieważ żaden z obecnie używanych modeli nie mógł działać wyjątkowo dobrze.30 Potrzebne są dalsze prospektywne badania w celu oceny wartości tych skal dla lepszej oceny priorytetu przeszczepienia wątroby.31
Aktualnie prowadzone są badania nad idealnym modelem prognostycznym, który pomoże upewnić się, że wszystkie dzieci potrzebujące przeszczepienia wątroby je otrzymają (wyższa czułość i dodatnia wartość predykcyjna, PPV), a te, które przeżyłyby bez przeszczepienia, nie będą mu poddawane (wyższa swoistość i ujemna wartość predykcyjna, NPV).32
Kolejne rozdziały
Zapraszamy do dalszego czytania naszego leksykonu.
Wybierz kolejny rozdział z menu poniżej, aby otworzyć nową podstronę kompedium wiedzy i uzyskać szczegółowe informację o leku, substancji lub chorobie.
Materiały źródłowe
- #1 Acute Liver Failure Prognostic Criteria: It’s Time to Revisithttps://pmc.ncbi.nlm.nih.gov/articles/PMC9929612/
Acute liver failure (ALF) is a devastating disease, and patients are at a higher risk of death without liver transplantation. Indicators are needed to identify the risk of death in ALF, which will help in the timely referral of patients to specialized centers. Clichy criteria and Kings College Hospital (KCH) criteria are the most widely used prognostic criteria. Real-life application of Clichy criteria is limited due to the non-availability of factor V level measurement. KCH criteria have good specificity but low sensitivity to predict outcomes. Therefore, we attempted to use the model for end-stage liver disease (MELD) score and chronic liver failure-sequential organ failure assessment (CLIF-SOFA) score in ALF patients as prognostic indicators and need for liver transplantation. […] In our study, we used MELD score and CLIF-SOFA as prognostic markers, and we concluded that CLIF-SOFA is a better predictor of mortality than MELD score in terms of sensitivity, specificity, NPV, PPV, and diagnostic accuracy. AUROC for CLIF-SOFA score is higher when compared to the MELD score.
- #2 Incorporating dynamics for predicting poor outcome in acute liver failure patientshttps://www.wjgnet.com/1948-9366/full/v4/i12/281.htm
Acute liver failure (ALF), also known as fulminant hepatic failure (FHF), is a devastating clinical syndrome with a high mortality of 60%-90%. An early and exact assessment of the severity of ALF together with prediction of its further development is critical in order to determine the further management of the patient. […] A number of prognostic models have been used for outcome prediction in ALF patients but they are mostly based on the variables measured at one time point, mostly at admission. […] Since ALF is a dynamic process, admission values of prognostic variables change over time during the clinical course of the patient. […] The timely prediction of spontaneous recovery helps to prevent LT and also the need for lifelong immunosuppressive therapy. Predicting whether the patient with ALF will require LT or will survive by only intensive medical care remains, however, challenging.
- #3 Prediction of Poor Outcome in Patients with Acute Liver FailureâSystematic Review of Prediction Models | PLOS Onehttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0050952
Acute liver failure is a rare disease with high mortality and liver transplantation is the only life saving therapy. Accurate prognosis of ALF is crucial for proper intervention. […] The timely prediction of spontaneous recovery helps prevent LT and also the need for lifelong immunosuppressive therapy. Timely assessing the likelihood of mortality is important for decisions on emergency liver transplantation. […] The models have shown inconsistent reproducibility, prognostic accuracy and therefore cannot be taken to reliably predict mortality in ALF and the need for a better prognostic model remains. […] There are many studies on prognostic models for ALF but they show methodological and reporting limitations. Future studies could be improved by better reporting and handling of missing data, the inclusion of model calibration aspects, use of absolute risk measures, explicit considerations for variable selection, the use of a more extensive set of reference models and more thorough validation.
- #4 Acute Liver Failure: Practice Essentials, Background, Pathophysiologyhttps://emedicine.medscape.com/article/177354-overview
- #5 Acute Liver Failure: Practice Essentials, Background, Pathophysiologyhttps://emedicine.medscape.com/article/177354-overview
- #6 Prognostic Indicators for Acute Liver Failure Development and Mortality in Patients with Hepatitis A: Consecutive Case Analysishttps://pmc.ncbi.nlm.nih.gov/articles/PMC4075399/
Due to the seroepidemiological shift in hepatitis A (HA), its severity, mortality, and complications have increased in recent years. Thus, the aim of this study was to identify predictive factors associated with poor prognosis among patients with HA. […] The mean age of patients (204 males, 100 females) was 32 years. Eighteen (5.9%) patients had progressed to ALF. Of the patients with ALF, 10 patients (3.3%) showed spontaneous survival while 8 (2.6%) died or underwent liver transplantation. Multivariate regression analysis showed that Model for End-Stage Liver Disease (MELD) and systemic inflammatory response syndrome (SIRS) scores were significant predictive factors of ALF. […] MELD and SIRS scores 23.5 and 3, respectively, appeared to be related to ALF development. In addition, KCC and SIRS scores 3 were valuable in predicting mortality of patients with a MELD 23.5.
- #7 Prognostic Indicators for Acute Liver Failure Development and Mortality in Patients with Hepatitis A: Consecutive Case Analysishttps://pmc.ncbi.nlm.nih.gov/articles/PMC4075399/
The MELD score was a powerful tool for predicting ALF development in patients with HA compared to DM, ALT, albumin, RDW 13.5, and the SIRS score. […] To cure more HA-related ALF patients, early liver transplantation is important, and prognostic factors for the prediction of ALF development are needed. In our study, higher MELD (23.5) and SIRS (3) scores appeared to be related to the development of ALF in patients with HA. Furthermore, in patients with a higher MELD score (23.5), those with a SIRS score 3 and who fulfilled KCC may need urgent liver transplantation.
- #8 Evidence-based incorporation of key parameters into MELD score for acute-on-chronic liver failure | eGastroenterologyhttps://egastroenterology.bmj.com/content/2/3/e100101
The model for end-stage liver disease (MELD) score is widely used for the prognostication in end-stage liver disease but has limited performance in acute-on-chronic liver failure (ACLF). […] CATCH-LIFE-MELD score, a modified MELD score exhibited improved accuracy in predicting the short-term prognosis of ACLF than other traditional scores. […] Patients with acute-on-chronic liver failure (ACLF) are at high-risk mortality, and accurate prediction of short-term outcomes is crucial for managing patients with ACLF. […] The model for end-stage liver disease (MELD) score is extensively used for the prognostic evaluation of ACLF, yet its efficacy is constrained. […] CATCH-LIFE-MELD score can be used for predicting and stratifying the risk of death in patients with ACLF, providing direction for future research on new therapeutic approaches. […] The new CATCH-LIFE-MELD score performed better than other traditional scores for ACLF.
- #9https://www.xiahepublishing.com/m/2310-8819/JCTH-2024-00316
The MELD-complication score integrates laboratory values and essential clinical complications, thereby enhancing the prediction of short-term outcomes for ACLF patients. […] The MELD-complication score can be used to stratify mortality risk among ACLF patients, effectively identify high-risk individuals, and demonstrate robustness in two external cohorts, with distinct ACLF etiologies. […] This new model, which integrates the MELD score with significant complications and indicators of systemic inflammatory response, demonstrated superior predictive accuracy for short-term mortality compared to traditional scores such as MELD, MELD 3.0, and ALBI.
- #10 Acute Liver Failure Prognostic Criteria: It’s Time to Revisithttps://pmc.ncbi.nlm.nih.gov/articles/PMC9929612/
Patients who did not survive had higher INR, MELD, CLIF-SOFA scores, and hepatic encephalopathy (HE) grades. Five patients who had a combination of MELD 30 and CLIF-SOFA 10, expired. […] The mortality rate in the study population was 37.5%. patients who did not survive had higher INR, HE grades, MELD scores, and CLIF-SOFA scores. […] Hepatic encephalopathy was found to be a predictor of mortality in various studies. […] CLIF-SOFA score correlates best with the final outcome of the patients having ALF as demonstrated by various literature all over the world.
- #11 Pediatric chronic liver failure-sequential organ failure assessment score and outcome of acute liver failure in childrenhttps://www.termedia.pl/Pediatric-chronic-liver-failure-sequential-organ-failure-assessment-score-and-outcome-of-acute-liver-failure-in-children,80,41821,1,1.html
On admission, pCLIF-SOFA score of the non-survival group (11 [7-13]) was significantly higher than that of the survival group (8 [7-11]). […] Both pCLIF-SOFA and PELD/MELD scores, on admission, at cut-off values 8 and 30, respectively, could predict death in children with ALF with higher AUC for pCLIF-SOFA score (0.88, 95% CI: 0.74-0.96, p0.001) than that of PELD/MELD score (0.76, 95% CI: 0.61-0.88,p = 0.001). […] In conclusion, the pCLIF-SOFA score is better than the PELD/MELD score as a predictor of death in PALF and can be used for accurate selection of children with ALF who are in a real need of LT.
- #12 Incorporating dynamics for predicting poor outcome in acute liver failure patientshttps://www.wjgnet.com/1948-9366/full/v4/i12/281.htm
Acute liver failure (ALF), also known as fulminant hepatic failure (FHF), is a devastating clinical syndrome with a high mortality of 60%-90%. An early and exact assessment of the severity of ALF together with prediction of its further development is critical in order to determine the further management of the patient. […] A number of prognostic models have been used for outcome prediction in ALF patients but they are mostly based on the variables measured at one time point, mostly at admission. […] Since ALF is a dynamic process, admission values of prognostic variables change over time during the clinical course of the patient. […] The timely prediction of spontaneous recovery helps to prevent LT and also the need for lifelong immunosuppressive therapy. Predicting whether the patient with ALF will require LT or will survive by only intensive medical care remains, however, challenging.
- #13 Incorporating dynamics for predicting poor outcome in acute liver failure patientshttps://www.wjgnet.com/1948-9366/full/v4/i12/281.htm
A number of prognostic models have been used for outcome prediction in ALF patients to select patients in need for LT. […] The models have shown inconsistent reproducibility of prognostic accuracy, and the need for a better prognostic model remains. […] The authors found that early changes of prognostic markers predict outcome better than the static baseline levels. […] This observation is supported by the systematic review of Minne et al that underlined the association between the dynamics of the Sequential Organ Failure Assessment score with hospital mortality in the intensive care. […] The ALFED model was also compared with the established prognostic models KCC and MELD. The results of this comparison showed that performance of MELD and KCC criteria was inferior to the ALFED model in the two cohorts, although no statistical testing was attempted for comparison. […] Based on our above considerations we conclude that ALFED is a well constructed and well reported model which seems to be worthwhile to test in ALF patients in other parts of the world with different aetiologies.
- #14 Acute-on-chronic liver failure: an update | Guthttps://gut.bmj.com/content/66/3/541
The majority of patients achieved their final grade of ACLF within the first week; therefore, the assessment of ACLF grade at days 3-7 after diagnosis predicted 28-day and 90-day mortality more accurately than ACLF grade at diagnosis. […] CLIF-C ACLF score showed a significantly higher predictive accuracy than MELD, MELD-Na and Child-Pugh-Turcotte score at all main time points after ACLF diagnosis (28, 90, 180 and 365 days).
- #15 Acute-on-chronic liver failure: an update | Guthttps://gut.bmj.com/content/66/3/541
Acute-on-chronic liver failure (ACLF) is a syndrome characterised by acute decompensation of chronic liver disease associated with organ failures and high short-term mortality. […] Using a liver-adapted sequential organ assessment failure score, it is possible to triage and prognosticate the outcome of patients with ACLF. […] Most of the patients will have a clear prognosis between day 3 and 7 of hospital admission and clinical decisions such as evaluation for liver transplant or discussion over goals of care could be tailored using clinical scores. […] ACLF grade at diagnosis is associated with short-term prognosis, with patients with ACLF grade 3 showing the worst prognosis compared with that of patients with ACLF grade 1 and 2. […] Data from the CANONIC study showed overall 28-day mortality of 33% of all cases of ACLF, and specific 28-day mortality rates in patients with ACLF grade 1, 2 and 3 was 22%, 32% and 73%, respectively.
- #16 A Dynamic Model for Predicting Outcome in Patients with HBV Related Acute-On-Chronic Liver Failure | Annals of Hepatologyhttps://www.elsevier.es/en-revista-annals-hepatology-16-articulo-a-dynamic-model-for-predicting-S1665268119301942
A Dynamic Model for Predicting Outcome in Patients with HBV Related Acute-On-Chronic Liver Failure […] Introduction and aim. Accurately predicting the prognosis of individual patient is crucial in the management of ACLF. We aimed to establish a specific prognostic model for HBV-related ACLF patients treated with nucleoside analog (NA). […] Results. The area under receiver operating characteristic curve (AUC) of the model for predicting 90-day mortality was 0.86, which was significantly higher than that of model for end stage liver disease(MELD), MELD-Na, CLIF-SOFA, MELD (7d) and MELD-Na (7d), ACLIF- SOFA(7d) (all p 0.01). The AUC of our model in the validation group was 0.79 which was superior to MELD (0.45) CLIF-SOFA (0.53) score in group B patients (p 0.01). […] Conclusion. In conclusion, the model was superior to the conventional methods in predicting the outcomes of patients with HBV related ACLF treated with NA. It is the first description of a novel prognostic model using consecutive data in patients with HBV-induced acute-on-chronic liver failure (ACLF) treated by nucleoside analogs.
- #17https://journals.lww.com/ccejournal/fulltext/2024/02000/liver_elastography_in_acute_liver_failure__a_pilot.10.aspx
In this pilot study, we showed that elastography has the potential to be used in acute liver failure and prognosticate outcome on day 7 of admission. […] The current transplant criteria identify ALF patients with poor prognosis with 58% sensitivity and 89% specificity thus there is an urgent need for new bedside tools to aid in prognostication. […] However, the trend during the first 10 days of admission was different between the two groups. LSM peaked at day 5 in spontaneous survivors with subsequent reduction during the recovery phase. In contrast, patients with a poor prognosis exhibited persistently increased LSM, and by day 7 of admission, the two groups displayed statistically different LSM values. […] We also calculated a ratio between day 7 LSM and baseline, which showed a trend, although not statistically significant, of increment in patients with a poor prognosis. […] Further studies, in a larger cohort, are needed to better understand the diagnostic role of liver stiffness in acute liver failure and whether the addition of these values to existing prognostic criteria could improve their sensitivity and specificity.
- #18https://journals.lww.com/ccejournal/fulltext/2024/02000/liver_elastography_in_acute_liver_failure__a_pilot.10.aspx
We aimed to assess the feasibility and reliability of sequential ultrasonographic and elastographic monitoring in acute liver failure (ALF). […] At admission, liver stiffness measurement (LSM) of the right lobe was statistically different between HC individuals (5.62 kPa), ALF (31.717 kPa), and ACLF (76.371 kPa) patients (ALF vs. ACLF, p = 0.0301). […] At admission, LSM was not different between ALF patients who spontaneously survived versus patients who died or were transplanted in the following 90 days. However, the trend over the first 10 days of admission was different with a peak of LSM at day 5 in spontaneous survivors followed by reduction during the recovery phase. ALF patients with poor prognosis showed a persistently increased LSM. […] In ALF stiffness peaks at day 5 of admission with subsequent reduction in patients spontaneously surviving, showing significant difference according to the prognosis at day 7 of admission. LSM might be useful in distinguishing acute from acute-on-chronic liver failure together with spleen volume and stiffness.
- #19 Predicting Outcome on Admission and Post-Admission for Acetaminophen-Induced Acute Liver Failure Using Classification and Regression Tree Models | PLOS Onehttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0122929
Assessing prognosis for acetaminophen-induced acute liver failure (APAP-ALF) patients often presents significant challenges. […] We aimed to improve determinations of prognosis both at the time of and following admission for APAP-ALF using Classification and Regression Tree (CART) models. […] CARTs offer simple prognostic models for APAP-ALF patients, which have higher AUROC and SN than KCC, with similar AC and negligibly worse SP. Admission and post-admission predictions were developed. […] Prognostication in acetaminophen-induced acute liver failure (APAP-ALF) is challenging beyond admission. […] Little has been published regarding the use of Kings College Criteria (KCC) beyond admission and KCC has shown limited sensitivity in subsequent studies. […] Data from the ALFSG registry suggested that CART prognosis models for the APAP population offer improved sensitivity and model performance over traditional regression-based KCC, while maintaining similar accuracy and negligibly worse specificity.
- #20 Predicting Outcome on Admission and Post-Admission for Acetaminophen-Induced Acute Liver Failure Using Classification and Regression Tree Models | PLOS Onehttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0122929
KCC-CART models offered modest improvement over traditional KCC, with NEW-CART models performing better than KCC-CART particularly at late time points. […] In this analysis, CART models modestly increased predictive performance of 21-day death/LT compared to traditional regression-derived KCC using United States ALFSG data. […] KCC-CART trees improved considerably the sensitivity and AUROC and provided similar predictive accuracy compared to traditional KCC, while NEW-CART models provide further but marginal improvement over KCC-CART models on admission. […] A limitation of the post-admission KCC-CART model was that it used creatinine without considering whether or not patients were on RRT. Therefore, the post-admission NEW-CART model may be preferable for prediction compared to the KCC-CART. […] In summary, both KCC-CART and NEW-CART models have benefits and could be used in predicting death/LT of new APAP-ALF patients for admission and post-admission.
- #21 Predicting the prognosis in acute liver failure: results from a retrospective pilot study using the LiMAx test | Annals of Hepatologyhttps://www.elsevier.es/en-revista-annals-hepatology-16-articulo-predicting-prognosis-in-acute-liver-S1665268119313390
Predicting the prognosis in acute liver failure: results from a retrospective pilot study using the LiMAx test […] To evaluate maximal liver function capacity (LiMAx) for predicting the prognosis of ALF. […] Maximal liver function capacity determined by LiMAx test is severely impaired in patients with ALF. The LiMAx test might be effective in predicting the individual prognosis and the need for LTX in ALF. […] The present pilot study presents for the first time the clinical significance of the maximal liver function capacity in ALF. It is shown that the LiMAx test cannot only determine ALF itself, but can potentially differentiate between those patients with spontaneous recovery and those that require urgent listing for LTX. […] The detailed case reports show the potential application of the LiMAx test in patients with ALF. The definite advantage of the LiMAx test is its sensitivity for short-term changes that cannot be provided by any biochemical test. […] In conclusion, maximal liver function capacity determined by the LiMAx test is markedly impaired in patients with ALF. The extent of functional impairment might be a very valuable parameter for predicting the individual prognosis and the need for LTX.
- #22https://link.springer.com/article/10.1007/s12072-022-10363-2
Acute-on-chronic liver failure (ACLF) is characterized by the development of a syndrome associated with a high risk of short-term death in patients with acute decompensated cirrhosis, and better indicators are needed to predict such outcomes. […] Sarcopenia was an independent risk factor for progression in the ACLF population (HR 3.771 95% CI 2.114-6.727, p<0.001). [...] We demonstrate that sarcopenia is a simple and objective indicator for predicting short-term prognosis in patients with ACLF. [...] AMPAS1 was a good predictor, with an area under the ROC curve of 0.865, and the cut-off value for poor outcome prediction was 0.31 (sensitivity 79.4%, specificity 76.4%). [...] Our analyses of a cohort of patients with ACLF revealed three major findings. First, to our knowledge, this is the first study to report sarcopenia as an independent risk factor for progression in an ACLF population.
- #23https://link.springer.com/article/10.1007/s12072-022-10363-2
Our new model, AMPAS1, was a good predictor of such outcomes. […] The present study indicates that sarcopenia is a simple and objective indicator that can predict the 90 day prognosis of patients with ACLF. […] AMPAS1 is a better model to predict 90 day adverse outcomes in patients with ACLF than the conventional prognostic scores.
- #24 Epidemiology of acute liver failure in Egyptian children | Egyptian Liver Journal | Full Texthttps://eglj.springeropen.com/articles/10.1186/s43066-024-00346-3
The study included 154 patients who fulfilled the definition of ALF were included. Their age ranged from 7 months to 17 years, with a median of 5.8 years. Mortality was the outcome for 73 patients (47.4%). The prognostic factors associated with mortality were elevated international normalized ratio (INR), total bilirubin (TB), creatinine, and ammonia levels at presentation with cutoff values (2.97, 21.15, 0.385, and 212, respectively). […] The mortality rate is high, and most of the deaths occurred early in the first 5 days of admission. So, early preparation for liver transplantation is recommended. Higher values of INR, TB, and creatinine above the cutoff levels at presentation may be potential markers for predicting death in affected children. […] The high mortality rate in the first 5 days of admission may be due to the inability to identify the etiology in undiagnosed cases in addition to a lack of awareness about the disease and delayed reference of cases.
- #25https://www.xiahepublishing.com/m/2310-8819/JCTH-2024-00316
Early determination of prognosis in patients with acute-on-chronic liver failure (ACLF) is crucial for optimizing treatment options and liver allocation. […] The study included 1,386 ACLF patients and identified six independent predictors of 28-day mortality through multivariate analysis (all p<0.05). [...] This study presents a refined prognostic model, the Model for end-stage liver disease-complication score, which accurately predicts short-term mortality in ACLF patients. [...] The survival curve showed that as the number of complications increased, the survival rate of patients decreased significantly. [...] The results of the multivariate analysis revealed that HE, pulmonary infection, and SBP were independent risk factors for short-term mortality and were indeed the most important complications for short-term mortality.
- #26 Acute Liver Failure: Practice Essentials, Background, Pathophysiologyhttps://emedicine.medscape.com/article/177354-overview
- #27 Clinical profile and outcome among patients with acute-on-chronic liver failure admitted in the intensive care unit | The Egyptian Journal of Internal Medicine | Full Texthttps://ejim.springeropen.com/articles/10.1186/s43162-021-00061-0
Acute-on-chronic liver failure (ACLF) has been recently defined as a clinical form including acute hepatic decompensation and high 28-day mortality. […] CLIF-C ACLF is assumed to be a highly prognostic score for mortality in ACLF patients better than other scores. […] There is a significant difference between the 3 ACLF groups regarding 1-month and 3-month mortalities in patients admitted to the ICU. […] Mortality is high in ACLF and increases with the number of organ failures (40% in ACLF1 to 100% in ACLF3). […] CLIFC-ACLF is the most prognostic scoring system with a cut-off value of 57; above this value, mortality is a fact. […] Prognosis is associated with types and number of failed organs and this can be measured by the chronic liver failure (CLIF) organ failure (CLIF-OF) score.
- #28 Clinical profile and outcome among patients with acute-on-chronic liver failure admitted in the intensive care unit | The Egyptian Journal of Internal Medicine | Full Texthttps://ejim.springeropen.com/articles/10.1186/s43162-021-00061-0
The survival is considered zero in patients with a CLIF-C ACLF score 64 without urgent liver transplant. […] CLIF-C ACLF is assumed to be a highly prognostic score as regards mortality in ACLF patients as compared to other scores. […] Our study concluded an algorithm to stratify patients according to prognosis is needed, in order to monitor treatment responsiveness, determine emergency for transplantation, and decide allocation in the intensive care unit (ICU) and also to have a rational basis to decide futility. […] We found that CLIF-C ACLF was the best prognostic model as regards mortality, whereas CTP, APACHE, MELD, MELD Na+, and SOFA scores were statistically non-significant. […] We studied CLIC-C ACLF score ROC curve (AUC) = 0.972 with CI: 0.919, 1.025, cutoff point = 57 above which intensive care admission does not seem to benefit ACLF patients. […] Mortality is high in ACLF and increases with the number of organ failures (40% in ACLF1 to 100% in ACLF3).
- #29 Prediction of Poor Outcome in Patients with Acute Liver FailureâSystematic Review of Prediction Models | PLOS Onehttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0050952
In this review we identified, summarized and assessed the quality of available models in the literature for prediction of poor outcome in adult patients with ALF. […] Model development usually relied on regression analysis, including logistic, linear or Cox regression. The models were usually constructed from clinical and/or demographic data to predict mortality or survival, only four studies used the combined outcome of death and transplantation. […] However, half of the studies included small samples (100 patients) and performed no internal, temporal or external validation. None of the studies reported on how well the model was calibrated. […] This systematic review provides an overview of models for prediction of poor outcome in patients with acute liver failure. These prognostic models were developed to support clinicians’ decisions, but they should be improved before being clinically useful. Future studies could be improved by paying more attention to (internal) validation, the inclusion of model calibration aspects, better consideration of the transplantation patient group, better reporting and handling of missing data, use of absolute risk measures, explicit considerations for considering and selecting predictors, the use of a more extensive set of reference models, and the inclusion of continuous variables without categorizing them, as well as clear reporting on the study design.
- #30 Pediatric chronic liver failure-sequential organ failure assessment score and outcome of acute liver failure in childrenhttps://www.termedia.pl/Pediatric-chronic-liver-failure-sequential-organ-failure-assessment-score-and-outcome-of-acute-liver-failure-in-children,80,41821,1,1.html
Acute liver failure (ALF) in children is a dramatic clinical syndrome characterized by deterioration in liver function tests, and potentially associated with dysfunction in other organs. […] Despite new therapies and support measures, survival continues to be unsatisfactory, ranging between 10% and 40%. After the introduction of LT as a therapeutic option for patients with ALF, the survival rate reached 60% to 80%. […] When to list a child is critical for the success of LT, knowledge of sensitive prognostic markers could also determine whether there is a possibility of recovery without LT. […] The ideal prognostic model remains elusive, as none of the currently used models could perform extremely well. […] The aim of the present study was to investigate the prognostic accuracy of the pediatric chronic liver failure sequential organ failure assessment (pCLIF-SOFA) score in comparison to the Pediatric End-Stage Liver Disease (PELD)/MELD score in children with ALF admitted to our tertiary center.
- #31 Comparing Eight Prognostic Scores in Predicting Mortality of Patients with Acute-On-Chronic Liver Failure Who Were Admitted to an ICU: A Single-Center Experiencehttps://www.mdpi.com/2077-0383/9/5/1540
The results showed that APACHE III and CLIF-C ACLF scores were significantly superior to other models in predicting overall mortality as determined by time-dependent ROC curve analysis (AUROC: 0.817). […] In predicting the 28-day mortality, APACHE III showed no significant difference to CLIF-C OF, CLIF-C ACLF, and MELD. However, they were all statistically superior to MPM0-III and SAPs III. […] Therefore, from a research perspective, it is an interesting finding that APACHE III performed as well as CLIF-C ACLF based on ICU admission day data in predicting overall and other time-point mortality for those patients with ACLF admitted to the ICU. […] Further prospective study is warranted to assess the value of these scores for better liver transplantation priority assessment.
- #32 The Role of Predictive Models in the Assessment of the Poor Outcomes in Pediatric Acute Liver Failurehttps://www.mdpi.com/2077-0383/11/2/432
The predictive models are based on features derived from analysis of ALF cohorts, treated conservatively, without LT. […] There is no predictive model universally accepted for evaluating ALF outcomes in children, and all are based upon data and experiences in adults. […] An ideal predictive model in ALF will help us to be sure that all children needing an LT will receive it (higher sensitivity and positive predictive value, PPV), and those who would survive without LT would not have it (higher specificity and negative predictive value, NPV). […] Our study aimed to analyze PELD/MELD scores and KCCâs role in predicting the survival with native liver in children with ALF of different etiologies. […] The PELD score was significantly higher in patients with poor outcomes than survivors.